2006
DOI: 10.1002/bit.21277
|View full text |Cite
|
Sign up to set email alerts
|

High O2 affinity hemoglobin‐based oxygen carriers synthesized via polymerization of hemoglobin with ring‐opened 2‐chloroethyl‐β‐D‐fructopyranoside and 1‐o‐octyl‐β‐D‐glucopyranoside

Abstract: Second generation hemoglobin-based O(2) carriers (HBOCs) are being developed with high O(2) affinity (low P(50)) in order to suppress vasoconstriction elicited by over-oxygenating tissues, a problem associated with low O(2) affinity first generation HBOCs. Our group has previously investigated the polymerization of hemoglobin (Hb) with dialdehydes as a strategy for engineering high O(2) affinity HBOCs. In this study, two novel reactive dialdehydes were synthesized by ring-opening 2-chloroethyl-beta-D-fructopyr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
24
0

Year Published

2007
2007
2010
2010

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 14 publications
(25 citation statements)
references
References 48 publications
1
24
0
Order By: Relevance
“…Empty chromatography columns XK 26/40 (400 mm in length, 26 mm I.D., GE Healthcare, Piscataway, NJ) were packed with the anion exchange resin Q-sepharose XL (GE Healthcare). Tris(hydroxymethyl)aminomethane, NaCl, NaOH, EDTA, Triton X-100, HCl, KCN, KFe(CN) 6 , dialysis tubing with a molecular weight cutoff of 6-8 kDa and all other chemicals were purchased from Fisher Scientific (Pittsburgh, PA).…”
Section: Materials and Chemicalsmentioning
confidence: 99%
See 1 more Smart Citation
“…Empty chromatography columns XK 26/40 (400 mm in length, 26 mm I.D., GE Healthcare, Piscataway, NJ) were packed with the anion exchange resin Q-sepharose XL (GE Healthcare). Tris(hydroxymethyl)aminomethane, NaCl, NaOH, EDTA, Triton X-100, HCl, KCN, KFe(CN) 6 , dialysis tubing with a molecular weight cutoff of 6-8 kDa and all other chemicals were purchased from Fisher Scientific (Pittsburgh, PA).…”
Section: Materials and Chemicalsmentioning
confidence: 99%
“…A variety of HBOCs exist and include: recombinant Hbs [4], cross-linked Hbs [5], polymerized Hbs [6][7][8][9], PEGylated Hbs [10], liposome encapsulated Hbs [11][12][13], polymersome encapsulated Hbs [14] and other particle encapsulated Hbs [15][16][17]. In order to synthesize and/ or formulate these HBOCs, a pure source of Hb is needed.…”
Section: Introductionmentioning
confidence: 99%
“…There are many different types of HBOCs that are currently in development, including polymerized acellular Hbs [3][4][5][6][7], liposome encapsulated Hbs [8][9][10], polymersome encapsulated Hbs [11], and hydrogel-based O 2 carriers [12][13][14]. Since each of these HBOCs require purified stroma-free Hb as the starting material, it is essential to develop an efficient and streamlined purification method of Hb to ensure that the starting product is of high purity and high yield.…”
Section: Introductionmentioning
confidence: 99%
“…RBC substitutes currently in development include liposome-encapsulated Hb25 and cross-linked/polymerized Hb 69. Several of these hemoglobin-based oxygen carriers (HBOCs), such as Hemopure (Biopure, Cambridge, MA)10,11 and PolyHeme (Northfield Labs, Evanston, IL)12 have shown some promise in clinical applications.…”
Section: Introductionmentioning
confidence: 99%